Phase II study of lonidamine in metastatic breast cancer.

Thirty patients with previously treated metastatic breast cancer were entered in a phase II study with oral lonidamine. Twenty-eight patients are evaluable for toxicity and 25 for response. A partial remission was obtained in four patients (16%) and disease stability in 11 (44%): 10 patients progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Pronzato, P., Amoroso, D., Bertelli, G., Conte, P. F., Cusimano, M. P., Ciottoli, G. B., Gulisano, M., Lionetto, R., Rosso, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247009/
https://www.ncbi.nlm.nih.gov/pubmed/2930690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247009/
https://www.ncbi.nlm.nih.gov/pubmed/2930690

Ejemplares similares